GLPG-0259
- Generic Name
- GLPG-0259
- Drug Type
- Small Molecule
- Chemical Formula
- C24H26N8O2
- CAS Number
- 1195065-29-2
- Unique Ingredient Identifier
- 52EG7RFE6Y
- Background
GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability and Food Effect).
GLPG0259 Solid Formulation Bioavailability and Food Effect
- First Posted Date
- 2009-12-02
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 12
- Registration Number
- NCT01024517
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy Subjects
- First Posted Date
- 2009-10-05
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 24
- Registration Number
- NCT00989703
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
First-in-Human Single Ascending and Multiple Dose of GLPG0259
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 32
- Registration Number
- NCT00905138
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath